MARKET

FPMI

FPMI

Fluoropharma Med Inc
EXMKT
0.0001
NaN%
Closed 09:30 03/17 EDT
OPEN
--
PREV CLOSE
0.0001
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0001
52 WEEK LOW
0.0001
MARKET CAP
3.43K
P/E (TTM)
-0.0013
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at FPMI last week (0310-0314)?
Weekly Report · 14h ago
Weekly Report: what happened at FPMI last week (0303-0307)?
Weekly Report · 03/10 10:45
Weekly Report: what happened at FPMI last week (0224-0228)?
Weekly Report · 03/03 10:44
Weekly Report: what happened at FPMI last week (0217-0221)?
Weekly Report · 02/24 10:44
Weekly Report: what happened at FPMI last week (0210-0214)?
Weekly Report · 02/17 10:42
Weekly Report: what happened at FPMI last week (0203-0207)?
Weekly Report · 02/10 10:38
Weekly Report: what happened at FPMI last week (0127-0131)?
Weekly Report · 02/03 10:41
Weekly Report: what happened at FPMI last week (0120-0124)?
Weekly Report · 01/27 10:43
More
About FPMI
FluoroPharma Medical, Inc. is a biopharmaceutical company specializing in discovering, developing and commercializing molecular imaging pharmaceuticals with initial applications in the area of cardiology. The Company is focused on the development of cardiovascular imaging agents that detect and assess acute and chronic forms of coronary artery disease (CAD). It has two clinical-stage molecular imaging pharmaceutical product candidates: 18-F TPP (BFPET) and 18-F FCPHA (CardioPET). BFPET program employs a (18F)-labeled cationic lipophilic tetraphenylphosphonium ion as an imaging agent designed for use in stress-testing for patients with presumptive or proven CAD. It measures the extent and severity of cardiovascular disease through the detection of ischemic and infarcted myocardial tissue. CardioPET program employs Trans-9-(18F)-Fluoro-3, 4-Methyleneheptadecanoic Acid as a molecular imaging agent designed to assess myocardial blood flow and metabolism in patients with CAD.

Webull offers Fluoropharma Medical Inc stock information, including EXMKT: FPMI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FPMI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FPMI stock methods without spending real money on the virtual paper trading platform.